[Federal Register Volume 81, Number 199 (Friday, October 14, 2016)]
[Notices]
[Pages 71107-71108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24808]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Heritable Disorders in Newborns and
Children
AGENCY: Health Resources and Service Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is
hereby given that a meeting is scheduled for the Advisory Committee on
Heritable Disorders in Newborns and Children. This meeting will be open
to the public but advance registration is required to ensure sufficient
webinar capacity. The registration link is https://www.blsmeetings.net/achdncnovember2016/. The registration deadline is Wednesday, November
2, 2016, 11:59 p.m. Eastern Time.
DATES AND TIMES: November 3, 2016, 9:00 a.m. to 5:00 p.m. (Meeting time
is tentative.)
November 4, 2016, 9:00 a.m. to 1:00 p.m. (Meeting time is
tentative.)
ADDRESSES: This meeting will be held by webinar only.
FOR FURTHER INFORMATION CONTACT: Anyone interested in obtaining other
relevant information should contact Alaina Harris, Maternal and Child
Health Bureau, HRSA, Room 18W66, 5600 Fishers Lane, Rockville, Maryland
20857; email: [email protected].
SUPPLEMENTARY INFORMATION: The Advisory Committee on Heritable
Disorders in Newborns and Children (Committee), as authorized by the
Public Health Service Act, Title XI, Sec. 1111 (42 U.S.C. 300b-10),
was established to advise the Secretary of the Department of Health and
Human Services about the development of newborn screening activities,
technologies, policies, guidelines, and programs for effectively
reducing morbidity and mortality in newborns and children having, or at
risk for, heritable disorders. In addition, the Committee's
recommendations regarding additional conditions/inherited disorders for
screening that have been adopted by the Secretary are included in the
Recommended Uniform Screening Panel and constitute part of the
comprehensive guidelines supported by HRSA. Pursuant to section 2713 of
the Public Health Service Act, codified at 42 U.S.C. 300gg-13, non-
grandfathered health plans are required to cover screenings included in
the HRSA-supported comprehensive guidelines without charging a co-
payment, co-insurance, or deductible for plan years (i.e., policy
years) beginning on or after the date that is 1-year from the
Secretary's adoption of the condition for screening.
The Committee will hear presentations and discussions on topics
related to newborn screening activities, technologies, policies,
guidelines, and programs for effectively reducing morbidity and
mortality in newborns and children having, or at risk for, heritable
disorders. The Committee will also hear updates from the Laboratory
Standards and Procedures workgroup, Follow-up and Treatment workgroup,
and Education and Training workgroup. Agenda items are subject to
changes as priorities indicate. Tentatively, the Committee is expected
to review and/or vote on the following: Approving newborn screening
surveillance case definitions and whether or not the nominated
condition Guanidinoacetate Methyltransferase deficiency should be
referred for a full evidence-based review. The Committee will not be
voting on a proposed addition of a condition to the Recommended Uniform
Screening Panel. The meeting agenda will be available 2 days prior to
the meeting on the Committee's Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Members of the public may submit written and/or present oral
comments at the meeting. All comments are part of the official
Committee record. Advance registration is required to submit written
comments and/or present oral comments. Written comments must be
submitted by October 19, 2016, 11:59 p.m. Eastern Time in order to be
included in the November meeting briefing book. Written comments should
identify the individual's name, address, email, telephone number,
professional or business affiliation, type of expertise (i.e., parent,
researcher, clinician, public health, etc.), and the topic/subject
matter of comments.
Individuals who wish to provide oral comments must register by
October 30, 2016, 11:59 p.m. Eastern Time. To ensure that all
individuals who have registered to make oral comments can be
accommodated, the allocated time may
[[Page 71108]]
be limited. Individuals who are associated with groups or have similar
interests may be requested to combine their comments and present them
through a single representative. No audiovisual presentations are
permitted.
More information on the Advisory Committee is available at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-24808 Filed 10-13-16; 8:45 am]
BILLING CODE 4165-15-P